Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
4,610,457
-
Share change
-
-130,805
-
Total reported value
-
$706,052,480
-
Put/Call ratio
-
0%
-
Price per share
-
$153.14
-
Number of holders
-
245
-
Value change
-
-$20,429,552
-
Number of buys
-
80
-
Number of sells
-
107
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2023
As of 30 Jun 2023,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
245 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,610,457 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, Raymond James Financial Services Advisors, Inc., Royal Bank of Canada, LPL Financial LLC, RAYMOND JAMES & ASSOCIATES, Berger Financial Group, Inc, and OSAIC HOLDINGS, INC..
This page lists
247
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.